Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05842902

Resilience Mobile App for Teens and Young Adults With Cancer

Pilot Trial Testing Mobile Health Psychosocial Intervention for Adolescents and Young Adults With Cancer

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
80 (estimated)
Sponsor
Seattle Children's Hospital · Academic / Other
Sex
All
Age
12 Years – 25 Years
Healthy volunteers
Not accepted

Summary

The goal of this pilot trial is to examine whether a mobile app version of the Promoting Resilience in Stress Management (PRISM) intervention is acceptable, easy to use, and helps improve quality of life and mental health symptoms.

Detailed description

Adolescents and Young Adults (AYAs) with cancer are at risk of distress, anxiety, depression, and poor quality of life. The use of mobile applications for psychosocial symptom self-management is appealing to this demographic population but this has not yet been developed and tested. PRISM is a novel, brief, evidence-based 1:1 intervention that teaches stress management, goal-setting, meaning making, cognitive-behavioral, and mindfulness strategies. Here, we propose to test a mobile health (mHealth) version of PRISM, mPRISM. In a pilot randomized controlled trial, we will evaluate the feasibility, acceptability, and exploratory efficacy of mPRISM using a waitlist control design.

Conditions

Interventions

TypeNameDescription
BEHAVIORALmPRISMPRISM is a brief, 1:1, skills-based resilience intervention delivered in-person by trained layperson coaches. PRISM's development was based on iterative research within the AYA oncology population, stress and coping theory, resilience theory, and successful cognitive-behavioral and mindfulness interventions. mPRISM is a digital version of the PRISM program with no in-person delivery. mPRISM includes coping skills modules: managing stress, goal-setting, cognitive reframing, and meaning-making.

Timeline

Start date
2023-09-12
Primary completion
2027-06-01
Completion
2027-06-01
First posted
2023-05-06
Last updated
2025-07-20

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05842902. Inclusion in this directory is not an endorsement.